The conflicting findings of CB2 in lung cancer (2–4), therefore, suggest a heterogeneous role for CB2 in lung carcinogenesis, which most likely depends not only on CB2 expressing tumor cells, but also on the type of TME-infiltrating immune cells expressing CB2. This evidence concerns the gene CNR2 and lung carcinoma.